Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Poster

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Clinical Trials|January 1, 1981
2'-deoxycoformycin. A new anticancer agentD S Poster, J S Penta, S Bruno, et al.
Cancer Clinical Trials|January 1, 1980
Bis-diketopiperazine derivatives in clinical oncology: ICRF-159D S Poster, J Penta, S Marsoni, et al.
Cancer Clinical Trials|January 1, 1981
Acivicin. An antitumor antibioticD S Poster, S Bruno, J Penta, et al.
Cancer Treatment Reports|January 1, 1981
"High-dose" thymidine in clinical oncologyS Bruno, D S Poster, V H Bono, et al.
American Journal of Clinical Oncology|February 1, 1982
Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinomaD S Poster, S Bruno, J S Penta, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Clinical Trials|January 1, 1981
2'-deoxycoformycin. A new anticancer agentD S Poster, J S Penta, S Bruno, et al.
Cancer Clinical Trials|January 1, 1980
Bis-diketopiperazine derivatives in clinical oncology: ICRF-159D S Poster, J Penta, S Marsoni, et al.
Cancer Clinical Trials|January 1, 1981
Acivicin. An antitumor antibioticD S Poster, S Bruno, J Penta, et al.
Cancer Treatment Reports|January 1, 1981
"High-dose" thymidine in clinical oncologyS Bruno, D S Poster, V H Bono, et al.
American Journal of Clinical Oncology|February 1, 1982
Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinomaD S Poster, S Bruno, J S Penta, et al.
Pageof 2